Order results by:
| Issue | Title | |
| Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
| S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
| "... and botox groups (p>0.05). Relatox showed the good tolerability and safety that was comparable to those ..." | ||
| Vol 9, No 3 (2017) | Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke | Abstract similar documents |
| V. V. Gusev, O. A. Lvova, T. V. Balueva | ||
| "... Objective: to evaluate the safety, efficacy, and tolerability of the botulinum toxin A Relatox ..." | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... preparations (botox, dysport, xeomin) may be effective for managing local spasticity that deteriorates motor ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... per treatment cycle were as follows: Dysport was 400 to 1000 U, xeomin was 50 to 300 U, and Botox 200 ..." | ||
| Vol 17, No 1 (2025) | Analysis of the migraine characteristics in the perimenopause | Abstract similar documents |
| D. A. Klimentova, G. R. Tabeeva | ||
| "... of days with headache per month are significantly higher in perimenopause than in RA (p<0.05). The risk ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... in scores on the HAMD-17 scale was noted in the remission group from the 7th day of agomelatine therapy (p<0.05 ..." | ||
| Vol 12, No 2 (2020) | Quality of life indicators in assessing the results of various surgical treatment methods for cervical myelopathy | Abstract similar documents |
| A. A. Chekhonatsky, N. E. Komleva, V. N. Nikolenko, V. A. Chekhonatsky | ||
| "... .7±2.1 to 49.6±3.1 arbitrary units (arb. unit) (p<0.05) and in role physical functioning from 39.4±2 ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... ) 29.2–34.1; α<0.05); the disease duration was 4.69 months (CI 3.31–6.08; α<0.05); the EDSS scores ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... scores (p<0.05), lower MFI (p<0.05), and Spielberger-Hanin test scores (p<0.05) compared to the control ..." | ||
| Vol 13, No 6 (2021) | The effect of sleep duration on the risk of diabetes mellitus in an open population of men aged 45–64 years (international epidemiological studies) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, L. V. Shcherbakova, A. N. Tripelgorn, S. K. Malyutina, O. D. Rymar, S. V. Mustafina, I. V. Gagulin, A. V. Gafarova | ||
| "... , 7-hour sleep prevailed – 39.2%, 6- and 8-hour sleep – 25.3% each (÷2=7.774; df=5; p>0.05). In men ..." | ||
| Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
| V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
| "... there was an increase in the severity of anxiety up to 9.93±4.7 points (in the control group – 4.28±3.5 points; p≤0.05 ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... .001), the ability to memorize 12 words – from 7.5±1.8 to 8.7±2.1 words (p<0.05), categorical associations – from 14 ..." | ||
| Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
| O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
| "... with subclinical depression (n=116): CRP – 2.03 mg/l, МСР-1 – 0.66 ng/ml (р<0.05). Correlation analysis showed ..." | ||
| Vol 3, No 4 (2011) | Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease | Abstract similar documents |
| M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev | ||
| "... than in those with mixed and left IPFIAs (p<0.05). Left-sided PD onset was significantly more common ..." | ||
| Vol 14, No 4 (2022) | Effect of statins on oxidative stress and cognitive function in patients with cerebral atherosclerosis: results of a prospective cohort study | Abstract similar documents |
| K. V. Nikulina, O. V. Vorobieva, V. V. Fateeva | ||
| "... as a significant increase in attention- (by 1.5 points versus 0.1 points; p<0.05) and memory- (by 0.9 points ..." | ||
| Vol 14, No 6 (2022) | Features of pathogenesis and risk factors of in-hospital ischemic stroke | Abstract similar documents |
| S. V. Kolomentsev, N. V. Tsygan, I. A. Voznyuk, S. N. Yanishevskiy, E. I. Shermatyuk, O. M. Ilyina, I. V. Litvinenko | ||
| "... of strokes of another established etiology was 24.8% and was higher than in therapeutic (9.8%; p<0.05 ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... and discussion. After 3 months, only the piribedil group showed a significant neuropsychological improvement (p<0.05 ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Specific features of epilepsy in children with brain tumors | Abstract similar documents |
| G. V. Kalmykova, A. F. Neretina, Zh. Yu. Chefranova | ||
| "... epilepticus in 9% of the patients. Different types of generalized seizures were more common (53%; p≥0.05 ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Analysis of migraine characteristics in postmenopausal women | Abstract similar documents |
| D. A. Klimentova, O. V. Kosivtsova, A. V. Sergeev, G. R. Tabeeva | ||
| "... in patients in the PM than in patients in the RP [p<0.05; relative risk (RR) 1.77]. The risk of necessity ..." | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... IIIarterialhyper-tension (46.2% vs. 17.9% in group 2; p<0.05), had a history of ischemic stroke (38.5% vs. 5 ..." | ||
| Vol 15, No 3 (2023) | Prediction of restoration of swallowing function in patients with ischemic stroke and neurogenic dysphagia | Abstract similar documents |
| A. A. Borzdyko, V. I. Ershov, N. V. Gumalatova, T. Yu. Lozinskaya, E. D. Lutsai | ||
| "... in severity (p<0.05). In the cardioembolic subtype of IS, the probability of switching patients to self ..." | ||
| Vol 14, No 2 (2022) | Cognitive functions and professional status in the open population of Russia/Siberia among adults aged 25–44 years | Abstract PDF (Eng) similar documents |
| A. V. Sukhanov, M. I. Voevoda, E. A. Gromova, D. V. Denisova, V. V. Gafarov | ||
| "... words it reached 0.735 words, and in delayed recall – 1.096 words (p<0.05). Attention assessment using ..." | ||
| Vol 15, No 1 (2023) | Association of sleep disorders with various polymorphic variants of the 5-HTTLPR SNP rs25531 A>G gene in people aged 25–44 | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, M. A. Gubina, A. V. Gafarova | ||
| "... =11.397; df=4; p<0.05). In 19.6% of men and 21.5% of women, sleep duration was 6 hours per day, 5 ..." | ||
| Vol 11, No 3 (2019) | Secondary hypokalemic myoplegias | Abstract similar documents |
| T. G. Sakovets, E. I. Bogdanov | ||
| "... etiology, there were shorter (5.8±4-day) muscle weakness episodes (p<0.05). The SHM duration was recorded ..." | ||
| Vol 15, No 3 (2023) | Association of the circadian rhythm gene ARNTL/BMAL1 with personal anxiety among people aged 25–64 (WHO international program “MONICA-psychosocial (MOPSY)”) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, А. V. Gafarova | ||
| "... genotypes of the ARNTL gene was 2 times higher (p<0.05) in the general population and 2.4 times (p<0.05 ..." | ||
| Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
| E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
| "... those who did not take adamantanes (p<0.05). At the same time, there were no significant differences ..." | ||
| Vol 14, No 3 (2022) | The efficacy of ipidacrine in patients with diabetic polyneuropathy | Abstract similar documents |
| P. R. Kamchatnov, E. R. Barantsevich, A. V. Chugunov, A. A. Kabanov, B. A. Abusueva | ||
| "... group, the total scores on the NSS scale decreased by 37% (p<0.05) by the 60th day of treatment ..." | ||
| Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
| V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
| "... 2.92 [0; 6.7] to 1.95 [0; 3.07] (p<0.05). LCM demonstrated a high efficacy and a good tolerance ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... pressure level (p<0.05) and AH duration (p<0,05) were significantly associated with the severity of each ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Carpal tunnel syndrome: issues of diagnosis and treatment | Abstract similar documents |
| A. S. Gilveg, V. A. Parfenov, G. Yu. Evzikov | ||
| "... .24±0.41 at 1 and 12 months, respectively (p<0.05), the mean functional state score dropped from 2.92±0 ..." | ||
| Vol 11, No 3 (2019) | Posthypoxic encephalopathy in patients undergoing coronary artery bypass surgery: clinical, neuropsychological, and neuroimaging aspects | Abstract similar documents |
| O. A. Portik, Yu. N. Tsarevskaya, A. Yu. Efimtsev, T. M. Alekseeva, G. E. Trufanov | ||
| "... . Posthypoxic encephalopathy was diagnosed in 10 and 67% of patients in Group 1 and 2, respectively (p=0.05 ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... , a statistically significant improvement (p<0.05) was observed in group 1: reduction in headache frequency ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... – 3.6%, χ2 =24.142, df=8, p<0.01 and women – 3.7%, χ2 =15.538, df=8, p<0.05) only some heart diseases ..." | ||
| Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
| "... .8%) and effective AD in all groups. Also, escitalopram, vortioxetine, and venlafaxine (p˂0.05) showed high efficacy ..." | ||
| Vol 13, No 5 (2021) | Insomnia in chronic non-specific low back pain | Abstract similar documents |
| I. A. Lamkova, V. A. Parfenov | ||
| "... (p<0.05). Sleep quality between 7th and 90th days significantly improved only in the extended therapy ..." | ||
| Vol 10, No 3 (2018) | The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect | Abstract similar documents |
| S. P. Sergeeva, А. А. Savin, I. D. Breslavich, P. F. Litvitsky, V. V. Arkhipov | ||
| "... : hypercholesterolemia of days 1, 7 (p<0.01) and 21 (p<0.05), hypertension in day 1 (p<0.05), diabetes mellitus on days 1 ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... groups did not differ (p ≥ 0.05) in parameters such as pain intensity according to VAS (6.65 ± 1.93 and 6 ..." | ||
| Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
| A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
| "... (Cresp, C30:15, and CVals) in MS patients (p<0.05). The isometric contraction test showed a statistically ..." | ||
| Vol 4, No 2 (2012) | Secondary prevention of ischemic stroke: from recommendations to real clinical practice | Abstract similar documents |
| V A Shandalin, A V Fonyakin, L A Geraskina | ||
| "... with antithrombotic agents, indirect anticoagulants in particular (p < 0.05). ..." | ||
| Vol 4, No 2 (2012) | Influence of a complex of muscle-strengthening exercises on quality of life in lumbosacral pain | Abstract similar documents |
| I A Zaitseva | ||
| "... ascertained to be diminished statistically significantly (p <0.05). Conclusion. The developed procedure ..." | ||
| Vol 14, No 5 (2022) | The relationship between dissociative experiences and childhood trauma in nursing and midwifery students | Abstract PDF (Eng) similar documents |
| F. F. Arabpour, Sh. Amini, R. Bidaki, R. Ashtari, F. Sepehri, A. Moghadam Ahmadi, H. Bakhshi, B. Bozorg | ||
| "... and dissociative experiences score (P<0.05). Conclusion. The prevalence of dissociative experiences among ..." | ||
| Vol 15, No 2 (2023) | Readiness potential as a neurophysiological marker of functional movement disorders | Abstract PDF (Eng) similar documents |
| V. A. Tolmacheva, E. N. Dudnik, R. M. Shishorin, D. S. Petelin, V. E. Bezrukov, A. N. Gamirova, Yu. V. Dolgopolova, B. A. Volel | ||
| "... .69 ms versus 276.28±176.1 ms (p<0.05), and its amplitude: -0.85±0.294 μV versus -0.35±0.26 μV (p<0.05 ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| "... and with the comparison group (p<0.05). The use of Mexidol was accompanied by a decrease in the severity of complaints ..." | ||
| Vol 12, No 3 (2020) | The first experience with Angiovit in the combination treatment of acute COVID-19 infection | Abstract similar documents |
| A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, A. V. Ivanov, A. A. Kubatiev | ||
| "... from 5.88 to 4.12 days (p<0.05) and to the earlier hospital discharge of patients with an improvement ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... , emotional disorders, and headache in Group 1 was significantly lower than in Group 2 (p<0.05). According ..." | ||
| Vol 13, No 2 (2021) | Pain reliever combinations in treatment of patients with acute musculoskeletal back pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, D. I. Lebedeva, I. V. Choi | ||
| "... 7 days, in the 2nd group – 9 days (p<0.05). Complex therapy in group 1 was more effective than ..." | ||
| Vol 12, No 1 (2020) | Gender characteristics of therapy for genetic generalized epilepsy in adults | Abstract similar documents |
| I. V. Volkov, G. S. Karpovich, A. V. Kalina, O. K. Volkova | ||
| "... .03). The percentage of achievement of clinical and encephalographic remission (CER) was higher in Group 2 (p=0.05 ..." | ||
| Vol 11, No 1 (2019) | Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program) | Abstract PDF (Eng) similar documents |
| A. V. Gafarova, E. A. Gromova, D. О. Panov, I. V. Gagulin, E. A. Krymov, V. V. Gafarov | ||
| "... higher for men (95% confidence interval (CI), 1.42–7.69; p<0.05), and that was 3.6 times higher for women ..." | ||
| Vol 11, No 2 (2019) | Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients | Abstract similar documents |
| O. V. Vorobyeva, Zh. M. Sizova, L. M. Bogatyreva | ||
| "... of treatment, the Montreal Cognitive Assessment (MoCa) scores increased from 24.5Ѓ}0.8 to 27.5Ѓ}0.6 (p<0.05 ..." | ||
| Vol 8, No 1 (2016) | Opportunities in multimodal neuroimaging for optimizing thrombolytic therapy for ischemic stroke | Abstract similar documents |
| M. M. Odinak, I. A. Voznyuk, S. N. Yanishevsky, S. Yu. Golokhvastov, N. V. Tsygan, A. Yu. Polushin, R. V. Andreev, D. A. Mirnaya | ||
| "... , the odd ratio for cerebral edema in the acutest period of the disease is 39.4% (95% CI 2.57–2436; p<0.05 ..." | ||
| Vol 8, No 3 (2016) | Changes in EEG indices and serotonin concentrations in depression and anxiety disorders | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, A. A. Mitrofanov, N. V. Solovyeva, V. B. Vilyanov | ||
| "... in the theta and delta bands in the depression and AD groups (p < 0.05) and multidirectional changes ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... in the neuronal plasticity stimulation groups was significantly better than in the comparison group (p≤0.05 ..." | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... a more significant reduction in pain syndrome according to the VAS (3.5±0.6 cm; p=0.005) and PainDETECT ..." | ||
| Vol 15, No 4 (2023) | Psychosomatic correlations in mentally ill and mentally healthy women with infertility | Abstract similar documents |
| A. O. Nikolaevskaya, N. A. Tyuvina, V. D. Morozova, E. P. Kesler | ||
| "... onset of menstruation, scanty or heavy menstrual flow (p<0.05), irregularity or absence of menstruation ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... .12±21.39 (p<0.05), the number of correct answers in the SDMT test increased from 40.7±11.75 to 45.16±13 ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... .36 points; p<0.05) in patients prescribed with MexiB 6. The majority of patients noted a significant ..." | ||
| Vol 14, No 1 (2022) | Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... was 0.05 per year; in three cases, a subclinical exacerbation was noted - new Gd+ lesions on T2-weighted ..." | ||
| Vol 10, No 3 (2018) | Correlation of the aesthetic component of dental health and emotional state in patients with different anxiety levels | Abstract similar documents |
| O. I. Lobach, V. N. Nikolenko, E. K. Rustamova, N. V. Lapina, E. V. Kochurova, L. A. Skorikova, L. V. Gavrushova | ||
| "... .5 and 39±0.6, respectively (p ≤ 0.05 for both indicators), and at 6 months, these were 44±0.5 and 43±0 ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... .3 scores, respectively; p<0.05). Imbalance of angiogenic and antiangiogenic factors can cause disease ..." | ||
| Vol 7, No 3 (2015) | Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision | Abstract similar documents |
| Irina Gennadyevna Rudakova, Yu. A. Belova | ||
| "... . The analysis demonstrated significant differences (p<0.05) between Groups 1 and 2 in the following indicators ..." | ||
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... of awakenings that were associated by the patients with urges to urinate (p<0.05). ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | A personalized approach to the treatment of chronic tension-type headache: quality of life of patients | Abstract similar documents |
| K. M. Tlisova, D. S. Petelin, O. N. Voskresenskaya, B. A. Volel | ||
| "... intensity) and emotional experience of the pain (mental health, social functioning, life activity; p<0.05 ..." | ||
| Vol 15, No 1 (2023) | Efficacy of a combination of non-drug therapies in patients with non-dementia vascular cognitive impairment | Abstract similar documents |
| M. S. Novikova, V. V. Zakharov, N. V. Vakhnina | ||
| "... of treatment, in the 1st group the results of neuropsychological testing significantly (p<0.05) improved ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... coefficient R=-0.41) between the number of headache (HA) days per month and the MoCA score (p<0.05 ..." | ||
| Vol 13, No 2 (2021) | Gait rehabilitation in patients with spastic hemiparesis: new opportunities | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, A. S. Rodionov, D. I. Kremlyov, D. V. Averkiev, V. Yu. Lobzin, A. V. Guseva | ||
| "... ). Results and discussion. Comparison of both groups on the 2nd CT showed significantly (p<0.05) better ..." | ||
| Vol 3, No 2 (2011) | Therapy of depression in patients with focal epilepsy: experience with citalopram use | Abstract similar documents |
| A. V. Lebedeva, E. G. Melikyan, A. B. Gekht | ||
| "... and the degree of depression rated by HDRS (r=-0.94, p<0.05) prior to and 12 weeks after citalopram therapy ((r ..." | ||
| Vol 16, No 1 (2024) | Cortisol as a cerebral cortex neurons apoptosis regulator in acute phase of ischemic stroke (clinical and pathological study) | Abstract PDF (Eng) similar documents |
| S. P. Sergeeva, A. A. Savin, P. F. Litvitsky, L. R. Gorbacheva, A. V. Lyundup, I. D. Breslavich, L. A. Savin | ||
| "... , significant negative correlation was found with the concentrations of sFas (r=-0.177; p<0.05) and sFasL (r=-0 ..." | ||
| Vol 16, No 6 (2024) | Features of mental state and reproductive function in dynamics inmentally ill women with infertility | Abstract similar documents |
| A. O. Nikolaevskaya, N. A. Tyuvina, Yu. G. Tulpin, Yu. G. Zhilyaeva | ||
| "... in the context of secondary infertility (77.8%; p<0.05). Treatment of infertility by gynaecologists and mental ..." | ||
| Vol 16, No 6 (2024) | Complex treatment of patients with chronic non-specific back pain and comorbid disorders: a prospective clinical study | Abstract similar documents |
| A. A. Golovacheva, V. A. Golovacheva | ||
| "... significantly (p<0.05) higher than in group 2 (46.7% of patients). By month 3 of observation, the number ..." | ||
| Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
| D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
| "... (p<0.05) improvement in CF was found according the Montreal Cognitive Assessment (MoCA-test), Frontal ..." | ||
| 1 - 70 of 130 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
